Jennifer Buell
Chief Executive Officer at MiNK Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2023
5 years of board service in total across 2 boards, counting each seat separately. Longest: MiNK Therapeutics Inc., 2 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Agenus Inc. June 16, 202671.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | MiNK Therapeutics Inc. | Grant or award | +31,474 | $11.12 | $349,991 |
| Sep 9, 2025 | MiNK Therapeutics Inc. | Grant or award | +18,229 | $15.36 | $279,997 |
| May 2, 2025 | Agenus Inc. | Grant or award | +581 | $3.11 | $1,807 |
| Apr 18, 2025 | Agenus Inc. | Grant or award | +869 | $2.08 | $1,808 |
| Apr 4, 2025 | Agenus Inc. | Grant or award | +1,159 | $1.56 | $1,808 |
| Mar 21, 2025 | Agenus Inc. | Grant or award | +1,123 | $1.61 | $1,808 |
| Mar 7, 2025 | Agenus Inc. | Grant or award | +409 | $2.35 | $961 |
| Feb 21, 2025 | Agenus Inc. | Grant or award | +545 | $3.32 | $1,809 |
| Feb 21, 2025 | Agenus Inc. | Grant or award | +626 | $3.32 | $2,078 |
| Feb 7, 2025 | Agenus Inc. | Grant or award | +516 | $3.50 | $1,806 |
| Jan 24, 2025 | Agenus Inc. | Shares withheld for tax | −270 | $3.57 | $964 |
| Jan 24, 2025 | Agenus Inc. | Grant or award | +776 | $3.57 | $2,770 |
| Oct 11, 2023 | MiNK Therapeutics Inc. | Other | −695,750 | — | — |
| Oct 3, 2023 | MiNK Therapeutics Inc. | Shares withheld for tax | −65,000 | $0.94 | $61,100 |
| Oct 2, 2023 | MiNK Therapeutics Inc. | Shares withheld for tax | −58,550 | $1.04 | $60,892 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.